Early Prediction of Breast Cancer Therapy Response using Multiresolution Fractal Analysis of DCE-MRI Parametric Maps.


Journal

Tomography (Ann Arbor, Mich.)
ISSN: 2379-139X
Titre abrégé: Tomography
Pays: Switzerland
ID NLM: 101671170

Informations de publication

Date de publication:
03 2019
Historique:
entrez: 12 3 2019
pubmed: 12 3 2019
medline: 12 3 2019
Statut: ppublish

Résumé

We aimed to determine whether multiresolution fractal analysis of voxel-based dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parametric maps can provide early prediction of breast cancer response to neoadjuvant chemotherapy (NACT). In total, 55 patients underwent 4 DCE-MRI examinations before, during, and after NACT. The shutter-speed model was used to analyze the DCE-MRI data and generate parametric maps within the tumor region of interest. The proposed multiresolution fractal method and the more conventional methods of single-resolution fractal, gray-level co-occurrence matrix, and run-length matrix were used to extract features from the parametric maps. Only the data obtained before and after the first NACT cycle were used to evaluate early prediction of response. With a training (N = 40) and testing (N = 15) data set, support vector machine was used to assess the predictive abilities of the features in classification of pathologic complete response versus non-pathologic complete response. Generally the multiresolution fractal features from individual maps and the concatenated features from all parametric maps showed better predictive performances than conventional features, with receiver operating curve area under the curve (AUC) values of 0.91 (all parameters) and 0.80 (K

Identifiants

pubmed: 30854446
doi: 10.18383/j.tom.2018.00046
pii: TOMO-2018-00046
pmc: PMC6403033
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

90-98

Subventions

Organisme : NCI NIH HHS
ID : U01 CA154602
Pays : United States

Références

Ann Oncol. 2014 Jun;25(6):1128-36
pubmed: 24618153
Magn Reson Med. 2014 Apr;71(4):1592-602
pubmed: 23661583
NMR Biomed. 2014 Aug;27(8):887-96
pubmed: 24840393
Acad Radiol. 2009 Mar;16(3):283-98
pubmed: 19201357
Eur Radiol. 2012 Jul;22(7):1451-64
pubmed: 22562143
Breast Cancer Res. 2017 May 18;19(1):57
pubmed: 28521821
Transl Oncol. 2014 Feb 01;7(1):153-66
pubmed: 24772219
Magn Reson Imaging. 2007 Jan;25(1):1-13
pubmed: 17222711
Radiology. 2012 Apr;263(1):53-63
pubmed: 22438441
Clin Cancer Res. 2016 Jan 15;22(2):284-90
pubmed: 26773162
J Clin Oncol. 2007 Oct 1;25(28):4414-22
pubmed: 17785706
Med Image Anal. 2015 Apr;21(1):59-71
pubmed: 25595523
J Magn Reson Imaging. 2011 Nov;34(5):1099-109
pubmed: 22002757
J Am Med Inform Assoc. 2013 Nov-Dec;20(6):1059-66
pubmed: 23785100
CA Cancer J Clin. 2017 Mar;67(2):100-121
pubmed: 28170086
Tomography. 2017 Mar;3(1):23-32
pubmed: 28691102
Clin Cancer Res. 2008 Oct 15;14(20):6580-9
pubmed: 18927299
Dev Cell. 2010 Jun 15;18(6):884-901
pubmed: 20627072
Magn Reson Imaging. 2006 Sep;24(7):843-7
pubmed: 16916701
Eur J Cancer. 2012 Dec;48(18):3342-54
pubmed: 22766518
Radiology. 1983 Sep;148(3):839-43
pubmed: 6878708
Breast Cancer Res Treat. 2012 Apr;132(3):843-51
pubmed: 21750964
J Clin Oncol. 2012 May 20;30(15):1796-804
pubmed: 22508812
IEEE Trans Image Process. 2013 Nov;22(11):4422-35
pubmed: 24057004
Magn Reson Med. 2003 Dec;50(6):1151-69
pubmed: 14648563
Transl Oncol. 2016 Feb;9(1):8-17
pubmed: 26947876
Magn Reson Med. 2009 Aug;62(2):488-99
pubmed: 19466747
Ann Surg Oncol. 2012 May;19(5):1508-16
pubmed: 22193884
Radiology. 2011 Jul;260(1):68-78
pubmed: 21502383
Gland Surg. 2017 Feb;6(1):119-124
pubmed: 28210563
J Natl Cancer Inst Monogr. 2011;2011(43):103-7
pubmed: 22043053
Radiology. 2006 May;239(2):361-74
pubmed: 16543585
Magn Reson Med. 1991 Feb;17(2):357-67
pubmed: 2062210
J Med Imaging (Bellingham). 2018 Jan;5(1):011008
pubmed: 29134191
Transl Oncol. 2014 Feb 01;7(1):14-22
pubmed: 24772203
J Clin Oncol. 2008 Feb 10;26(5):778-85
pubmed: 18258986
J Magn Reson Imaging. 1999 Sep;10(3):223-32
pubmed: 10508281

Auteurs

Archana Machireddy (A)

Oregon Health and Science University, Portland, OR.

Guillaume Thibault (G)

Oregon Health and Science University, Portland, OR.

Alina Tudorica (A)

Oregon Health and Science University, Portland, OR.

Aneela Afzal (A)

Oregon Health and Science University, Portland, OR.

May Mishal (M)

Oregon Health and Science University, Portland, OR.

Kathleen Kemmer (K)

Oregon Health and Science University, Portland, OR.

Arpana Naik (A)

Oregon Health and Science University, Portland, OR.

Megan Troxell (M)

Oregon Health and Science University, Portland, OR.

Eric Goranson (E)

Oregon Health and Science University, Portland, OR.

Karen Oh (K)

Oregon Health and Science University, Portland, OR.

Nicole Roy (N)

Oregon Health and Science University, Portland, OR.

Neda Jafarian (N)

Oregon Health and Science University, Portland, OR.

Megan Holtorf (M)

Oregon Health and Science University, Portland, OR.

Wei Huang (W)

Oregon Health and Science University, Portland, OR.

Xubo Song (X)

Oregon Health and Science University, Portland, OR.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH